Enhanced Gut-to-Liver Oral Drug Delivery via Ligand-Modified Nanoparticles by Attenuating Protein Corona Adsorption
ACS Nano · 2024
DOI: 10.1021/acsnano.4c11453 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2024. Verfasst von Jie Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. Hauptthemen laut MEDLINE: Nanoparticles, Protein Corona, Liver, Drug Delivery Systems. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: China Association for Science and Technology, National Key Research and Development Program of China, Shanghai Institute of Materia Medica, Chinese Academy of Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
- School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, National Institutes for Food and Drug Control, Beijing 100050, China.
ORCID-Profile: Yong Gan, Miaorong Yu
Förderung
- China Association for Science and Technology
- National Key Research and Development Program of China
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- National Science Fund for Distinguished Young Scholars
- National Natural Science Foundation of China
- Chinese Academy of Sciences
- Shanghai Action Plan for Science, Technology, and Innovation
- Key Technology Program for Nucleic Acid Drugs of NCTIB
Zitieren
APA
Wang, J., Zhang, Z., Zhang, Z., Zou, Z., Zhuo, Y., Liu, C., Nie, D., Gan, Y., & Yu, M. (2024). Enhanced Gut-to-Liver Oral Drug Delivery via Ligand-Modified Nanoparticles by Attenuating Protein Corona Adsorption. ACS Nano. https://doi.org/10.1021/acsnano.4c11453
Vancouver
Wang J, Zhang Z, Zhang Z, Zou Z, Zhuo Y, Liu C, et al. Enhanced Gut-to-Liver Oral Drug Delivery via Ligand-Modified Nanoparticles by Attenuating Protein Corona Adsorption. ACS Nano. 2024. doi:10.1021/acsnano.4c11453
BibTeX
@article{Wang2024,
author = {Wang, Jie and Zhang, Zilong and Zhang, Zhuan and Zou, Zhiwen and Zhuo, Yan and Liu, Chang and Nie, Di and Gan, Yong and Yu, Miaorong},
title = {Enhanced Gut-to-Liver Oral Drug Delivery via Ligand-Modified Nanoparticles by Attenuating Protein Corona Adsorption},
journal = {ACS Nano},
year = {2024},
doi = {10.1021/acsnano.4c11453}
}
EUVIMED